1 Report Overview
1.1 Study Scope and Definition
1.2 Research Methodology
1.2.1 Methodology/Research Approach
1.2.2 Data Source
1.3 Key Market Segments
1.4 Players Covered: Ranking by Neuraminidase Inhibitor Revenue
1.5 Market Analysis by Type
1.5.1 Global Neuraminidase Inhibitor Market Size Growth Rate by Type: 2020 VS 2026
1.5.2 Zanamivir
1.5.3 Oseltamivir
1.5.4 Peramivir
1.5.5 Laninamivir
1.6 Market by Application
1.6.1 Global Neuraminidase Inhibitor Market Share by Application: 2021-2026
1.6.2 Hospital Pharmacies
1.6.3 Drug Stores
1.6.4 Retail Stores
1.6.5 Others
1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.7.2 Covid-19 Impact: Commodity Prices Indices
1.7.3 Covid-19 Impact: Global Major Government Policy
1.8 Study Objectives
1.9 Years Considered
2 Global Neuraminidase Inhibitor Market Trends and Growth Strategy
2.1 Market Top Trends
2.2 Market Drivers
2.3 Market Challenges
2.4 Porters Five Forces Analysis
2.5 Market Growth Strategy
2.6 SWOT Analysis
3 Global Neuraminidase Inhibitor Market Players Profiles
3.1 GlaxoSmithKline
3.1.1 GlaxoSmithKline Company Profile
3.1.2 GlaxoSmithKline Neuraminidase Inhibitor Product Specification
3.1.3 GlaxoSmithKline Neuraminidase Inhibitor Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.2 BioCryst
3.2.1 BioCryst Company Profile
3.2.2 BioCryst Neuraminidase Inhibitor Product Specification
3.2.3 BioCryst Neuraminidase Inhibitor Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.3 Gilead Sciences
3.3.1 Gilead Sciences Company Profile
3.3.2 Gilead Sciences Neuraminidase Inhibitor Product Specification
3.3.3 Gilead Sciences Neuraminidase Inhibitor Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 F. Hoffman-La Roche
3.4.1 F. Hoffman-La Roche Company Profile
3.4.2 F. Hoffman-La Roche Neuraminidase Inhibitor Product Specification
3.4.3 F. Hoffman-La Roche Neuraminidase Inhibitor Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Daiichi Sankyo
3.5.1 Daiichi Sankyo Company Profile
3.5.2 Daiichi Sankyo Neuraminidase Inhibitor Product Specification
3.5.3 Daiichi Sankyo Neuraminidase Inhibitor Production Capacity, Revenue, Price and Gross Margin (2015-2020)
4 Global Neuraminidase Inhibitor Market Competition by Market Players
4.1 Global Neuraminidase Inhibitor Production Capacity Market Share by Market Players (2015-2020)
4.2 Global Neuraminidase Inhibitor Revenue Market Share by Market Players (2015-2020)
4.3 Global Neuraminidase Inhibitor Average Price by Market Players (2015-2020)
5 Global Neuraminidase Inhibitor Production by Regions (2015-2020)
5.1 North America
5.1.1 North America Neuraminidase Inhibitor Market Size (2015-2020)
5.1.2 Neuraminidase Inhibitor Key Players in North America (2015-2020)
5.1.3 North America Neuraminidase Inhibitor Market Size by Type (2015-2020)
5.1.4 North America Neuraminidase Inhibitor Market Size by Application (2015-2020)
5.2 East Asia
5.2.1 East Asia Neuraminidase Inhibitor Market Size (2015-2020)
5.2.2 Neuraminidase Inhibitor Key Players in East Asia (2015-2020)
5.2.3 East Asia Neuraminidase Inhibitor Market Size by Type (2015-2020)
5.2.4 East Asia Neuraminidase Inhibitor Market Size by Application (2015-2020)
5.3 Europe
5.3.1 Europe Neuraminidase Inhibitor Market Size (2015-2020)
5.3.2 Neuraminidase Inhibitor Key Players in Europe (2015-2020)
5.3.3 Europe Neuraminidase Inhibitor Market Size by Type (2015-2020)
5.3.4 Europe Neuraminidase Inhibitor Market Size by Application (2015-2020)
5.4 South Asia
5.4.1 South Asia Neuraminidase Inhibitor Market Size (2015-2020)
5.4.2 Neuraminidase Inhibitor Key Players in South Asia (2015-2020)
5.4.3 South Asia Neuraminidase Inhibitor Market Size by Type (2015-2020)
5.4.4 South Asia Neuraminidase Inhibitor Market Size by Application (2015-2020)
5.5 Southeast Asia
5.5.1 Southeast Asia Neuraminidase Inhibitor Market Size (2015-2020)
5.5.2 Neuraminidase Inhibitor Key Players in Southeast Asia (2015-2020)
5.5.3 Southeast Asia Neuraminidase Inhibitor Market Size by Type (2015-2020)
5.5.4 Southeast Asia Neuraminidase Inhibitor Market Size by Application (2015-2020)
5.6 Middle East
5.6.1 Middle East Neuraminidase Inhibitor Market Size (2015-2020)
5.6.2 Neuraminidase Inhibitor Key Players in Middle East (2015-2020)
5.6.3 Middle East Neuraminidase Inhibitor Market Size by Type (2015-2020)
5.6.4 Middle East Neuraminidase Inhibitor Market Size by Application (2015-2020)
5.7 Africa
5.7.1 Africa Neuraminidase Inhibitor Market Size (2015-2020)
5.7.2 Neuraminidase Inhibitor Key Players in Africa (2015-2020)
5.7.3 Africa Neuraminidase Inhibitor Market Size by Type (2015-2020)
5.7.4 Africa Neuraminidase Inhibitor Market Size by Application (2015-2020)
5.8 Oceania
5.8.1 Oceania Neuraminidase Inhibitor Market Size (2015-2020)
5.8.2 Neuraminidase Inhibitor Key Players in Oceania (2015-2020)
5.8.3 Oceania Neuraminidase Inhibitor Market Size by Type (2015-2020)
5.8.4 Oceania Neuraminidase Inhibitor Market Size by Application (2015-2020)
5.9 South America
5.9.1 South America Neuraminidase Inhibitor Market Size (2015-2020)
5.9.2 Neuraminidase Inhibitor Key Players in South America (2015-2020)
5.9.3 South America Neuraminidase Inhibitor Market Size by Type (2015-2020)
5.9.4 South America Neuraminidase Inhibitor Market Size by Application (2015-2020)
5.10 Rest of the World
5.10.1 Rest of the World Neuraminidase Inhibitor Market Size (2015-2020)
5.10.2 Neuraminidase Inhibitor Key Players in Rest of the World (2015-2020)
5.10.3 Rest of the World Neuraminidase Inhibitor Market Size by Type (2015-2020)
5.10.4 Rest of the World Neuraminidase Inhibitor Market Size by Application (2015-2020)
6 Global Neuraminidase Inhibitor Consumption by Region (2015-2020)
6.1 North America
6.1.1 North America Neuraminidase Inhibitor Consumption by Countries
6.1.2 United States
6.1.3 Canada
6.1.4 Mexico
6.2 East Asia
6.2.1 East Asia Neuraminidase Inhibitor Consumption by Countries
6.2.2 China
6.2.3 Japan
6.2.4 South Korea
6.3 Europe
6.3.1 Europe Neuraminidase Inhibitor Consumption by Countries
6.3.2 Germany
6.3.3 United Kingdom
6.3.4 France
6.3.5 Italy
6.3.6 Russia
6.3.7 Spain
6.3.8 Netherlands
6.3.9 Switzerland
6.3.10 Poland
6.4 South Asia
6.4.1 South Asia Neuraminidase Inhibitor Consumption by Countries
6.4.2 India
6.5 Southeast Asia
6.5.1 Southeast Asia Neuraminidase Inhibitor Consumption by Countries
6.5.2 Indonesia
6.5.3 Thailand
6.5.4 Singapore
6.5.5 Malaysia
6.5.6 Philippines
6.6 Middle East
6.6.1 Middle East Neuraminidase Inhibitor Consumption by Countries
6.6.2 Turkey
6.6.3 Saudi Arabia
6.6.4 Iran
6.6.5 United Arab Emirates
6.7 Africa
6.7.1 Africa Neuraminidase Inhibitor Consumption by Countries
6.7.2 Nigeria
6.7.3 South Africa
6.8 Oceania
6.8.1 Oceania Neuraminidase Inhibitor Consumption by Countries
6.8.2 Australia
6.9 South America
6.9.1 South America Neuraminidase Inhibitor Consumption by Countries
6.9.2 Brazil
6.9.3 Argentina
6.10 Rest of the World
6.10.1 Rest of the World Neuraminidase Inhibitor Consumption by Countries
7 Global Neuraminidase Inhibitor Production Forecast by Regions (2021-2026)
7.1 Global Forecasted Production of Neuraminidase Inhibitor (2021-2026)
7.2 Global Forecasted Revenue of Neuraminidase Inhibitor (2021-2026)
7.3 Global Forecasted Price of Neuraminidase Inhibitor (2021-2026)
7.4 Global Forecasted Production of Neuraminidase Inhibitor by Region (2021-2026)
7.4.1 North America Neuraminidase Inhibitor Production, Revenue Forecast (2021-2026)
7.4.2 East Asia Neuraminidase Inhibitor Production, Revenue Forecast (2021-2026)
7.4.3 Europe Neuraminidase Inhibitor Production, Revenue Forecast (2021-2026)
7.4.4 South Asia Neuraminidase Inhibitor Production, Revenue Forecast (2021-2026)
7.4.5 Southeast Asia Neuraminidase Inhibitor Production, Revenue Forecast (2021-2026)
7.4.6 Middle East Neuraminidase Inhibitor Production, Revenue Forecast (2021-2026)
7.4.7 Africa Neuraminidase Inhibitor Production, Revenue Forecast (2021-2026)
7.4.8 Oceania Neuraminidase Inhibitor Production, Revenue Forecast (2021-2026)
7.4.9 South America Neuraminidase Inhibitor Production, Revenue Forecast (2021-2026)
7.4.10 Rest of the World Neuraminidase Inhibitor Production, Revenue Forecast (2021-2026)
7.5 Forecast by Type and by Application (2021-2026)
7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
7.5.2 Global Forecasted Consumption of Neuraminidase Inhibitor by Application (2021-2026)
8 Global Neuraminidase Inhibitor Consumption Forecast by Regions (2021-2026)
8.1 North America Forecasted Consumption of Neuraminidase Inhibitor by Country
8.2 East Asia Market Forecasted Consumption of Neuraminidase Inhibitor by Country
8.3 Europe Market Forecasted Consumption of Neuraminidase Inhibitor by Countriy
8.4 South Asia Forecasted Consumption of Neuraminidase Inhibitor by Country
8.5 Southeast Asia Forecasted Consumption of Neuraminidase Inhibitor by Country
8.6 Middle East Forecasted Consumption of Neuraminidase Inhibitor by Country
8.7 Africa Forecasted Consumption of Neuraminidase Inhibitor by Country
8.8 Oceania Forecasted Consumption of Neuraminidase Inhibitor by Country
8.9 South America Forecasted Consumption of Neuraminidase Inhibitor by Country
8.10 Rest of the world Forecasted Consumption of Neuraminidase Inhibitor by Country
9 Global Neuraminidase Inhibitor Sales by Type (2015-2026)
9.1 Global Neuraminidase Inhibitor Historic Market Size by Type (2015-2020)
9.2 Global Neuraminidase Inhibitor Forecasted Market Size by Type (2021-2026)
10 Global Neuraminidase Inhibitor Consumption by Application (2015-2026)
10.1 Global Neuraminidase Inhibitor Historic Market Size by Application (2015-2020)
10.2 Global Neuraminidase Inhibitor Forecasted Market Size by Application (2021-2026)
11 Global Neuraminidase Inhibitor Manufacturing Cost Analysis
11.1 Neuraminidase Inhibitor Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.3 Manufacturing Process Analysis of Neuraminidase Inhibitor
12 Global Neuraminidase Inhibitor Marketing Channel, Distributors, Customers and Supply Chain
12.1 Marketing Channel
12.2 Neuraminidase Inhibitor Distributors List
12.3 Neuraminidase Inhibitor Customers
12.4 Neuraminidase Inhibitor Supply Chain Analysis
13 Analyst's Viewpoints/Conclusions
14 Disclaimer